Primary tabs

Nanobiosym (NBS) Pilot Validation Study of Gene-RADAR Nanotechnology Platform Point-of-Care (POC) for Prevention of Mother to Child Transmission (PMTCT) of HIV in Rwanda

In collaboration with the Rwandan Ministry of Health & National Research Laboratory, and our on the ground implementing partners, Nanobiosym will reduce HIV related deaths in infants by scaling up access to its novel POC nanodiagnostic platform by validating Nanobiosym's proprietary Point-of-Care Gene-RADARĀ® diagnostic platform's ability to measure HIV positive mothers' viral load thereby ensuring they are responding to ART and reducing their chances of transmitting HIV to their child in-utero, at birth, or during the breastfeeding period.

Grant ID
SLAB-POC-0096-05
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Principal Investigator
Award Manager
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
330350.00
Funding Currency
CAD
Exchange Rate (at time of payment)
0.7500000000
Funding Amount (in USD)
247763.00
Funding Date Range
-
Funding Total (In US dollars)
247762.50
Co-Funded
False